Category Archives: Launched Drugs

Discovery of Rivaroxaban (Factor Xa Inhibitor)


The discovery of novel anticoagulants, and the search for novel orally active agents in particular, has been a long and difficult journey.  However, the recent (2008) launches of Bayer’s Factor Xa inhibitor (Rivaroxaban, BAY 59-7939) and Boehringer Ingelheim’s Thrombin inhibitor … Continue reading

Posted in Enzyme Inhibitors, Launched Drugs | Tagged , , , , , , , , , , , , | 1 Comment